GLP-1

Digital Daily

Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers

The Conversation - October 21, 2024

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be safe or...

Digital Daily

Alcohol use disorder can be treated with an array of medications – but few people have heard of them

The Conversation - May 27, 2024

Drugs used to treat alcohol use disorder have been on the market for decades but are rarely prescribed. Krit of Studio OMG/Moment via Getty...

Digital Daily

What happens when I stop taking a drug like Ozempic or Mounjaro?

The Conversation - May 19, 2024

Diva Plavalaguna/Pexels by Natasha Yates, Bond University Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually...

Digital Daily

Drugs like Ozempic won’t ‘cure’ obesity but they might make us more fat-phobic

The Conversation - April 21, 2024

by Emma Beckett, UNSW Sydney Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know...

GLP-1

Latest news

Cynthia A. Baldwin: Is this your America?

To Be Equal: Tell Congress to support families on SNAP

Halfway to chains: What’s already been enforced under Project 2025

Always watching: How ICE’s plan to monitor social media 24/7 threatens privacy and civic participation

Courier wins six first-place, two second-place statewide awards